Food and Drug Administration drug warnings can have an immediate negative impact on medication adherence among patients, even if the warnings are not safety related, according to new research sponsored by CVS Caremark.
Patients who take generic antidepressants will remain as adherent as those who take brand-name drugs to treat the condition, according to a new study.
